logo
Select company
Select metric
$ 6.11EBITDA per Share
VS
Market
77
Sector
92
Industry
98
History
100
$ 29.46Close
$ 13.63 - $ 41.99 52-Week Range
Ticker Information

Ticker

RIGL

Company Name

RIGEL PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

RIGEL PHARMACEUTICALS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RIGL - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ 109.3M$ 6.11117.89M
3/31/2025$ 48.45M$ 2.72117.81M
12/31/2024$ 28.51M$ 1.62117.58M
9/30/2024$ 13.67M$ 0.78117.6M
6/30/2024$ -4.92M$ -0.28117.55M
3/31/2024$ -10.98M$ -0.63117.52M
12/31/2023$ -16.98M$ -0.98117.4M
9/30/2023$ -17.13M$ -0.98117.44M
6/30/2023$ -31.6M$ -1.82117.37M
3/31/2023$ -39.84M$ -2.3117.36M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • RIGEL PHARMACEUTICALS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -1.49.
  • Over the past 5 years, RIGEL PHARMACEUTICALS INC's average EBITDAPS has been $ -0.91.
  • The median EBITDAPS for RIGEL PHARMACEUTICALS INC during this period was $ -0.92
  • RIGEL PHARMACEUTICALS INC reached its highest EBITDAPS over the past 5 years at $ 6.11.
  • The lowest EBITDAPS recorded by RIGEL PHARMACEUTICALS INC in the same timeframe $ -4.62

RIGEL PHARMACEUTICALS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
MRVI : MARAVAI LIFESCIENCES HOLDINGS INC $ -0.7KROS : KEROS THERAPEUTICS INC $ 0.75ARVN : ARVINAS INC $ -0.91RGNX : REGENXBIO INC $ -2.52VNDA : VANDA PHARMACEUTICALS INC $ -1.31CTMX : CYTOMX THERAPEUTICS INC $ 0.42XNCR : XENCOR INC $ -1.66ESPR : ESPERION THERAPEUTICS INC $ -0.16NKTR : NEKTAR THERAPEUTICS $ -6.68PBYI : PUMA BIOTECHNOLOGY INC $ 1.27

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for RIGEL PHARMACEUTICALS INC is calculated as follows: EBITDA [ $ -25.12M ] / (Shares WA [ 16.89M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -1.49 ]

RIGL - EBITDA per Share, Last 5 years

$ -4.62

Minimum

Mar 31, 2022

$ 6.11

Maximum

Jun 30, 2025

$ -0.91

Average

$ -0.92

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.02 with a standard deviation of $ 4.27.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 13.99
average$ 2.02
median$ 0.99
std$ 4.27